Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1971 Jul;24(5):410–418. doi: 10.1136/jcp.24.5.410

Clinical uses and control of rifampicin and clindamycin.

I Phillips
PMCID: PMC477019  PMID: 4999067

Full text

PDF
410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arioli V., Pallanza R., Furesz S., Carniti G. Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneimittelforschung. 1967 May;17(5):523–529. [PubMed] [Google Scholar]
  2. Bals M. G., Filipescŭ S. The antistaphylococcal activity of Rifampicin. Arzneimittelforschung. 1969 Aug;19(8):1285–1287. [PubMed] [Google Scholar]
  3. Baudens J. G., Chabbert Y. A. Rifampicine: bactéricidie et bactériopause. Pathol Biol (Paris) 1969 Apr;17(7):392–397. [PubMed] [Google Scholar]
  4. Berman J. D., Levine M. K. The efficacy of clindamycin in beta-hemolytic streptococcal infections of the upper respiratory tract. J Med Assoc Ga. 1969 Apr;58(4):155–157. [PubMed] [Google Scholar]
  5. Brodasky T. F., Argoudelis A. D., Eble T. E. The characterization and thin-layer chromatographic quantitation of the human metabolite of 7-deoxy-7(S)chlorolincomycin (U-21,251 F). J Antibiot (Tokyo) 1968 May;21(5):327–333. doi: 10.7164/antibiotics.21.327. [DOI] [PubMed] [Google Scholar]
  6. Cimino J. E., Tierno P. M., Jr Hemodialysis properties of clindamycin (7-chloro-7-deoxylincomycin). Appl Microbiol. 1969 Mar;17(3):446–448. doi: 10.1128/am.17.3.446-448.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Citron K. M., May J. R. Rifamycin antibiotics in chronic purulent bronchitis. Lancet. 1969 Nov 8;2(7628):982–983. doi: 10.1016/s0140-6736(69)90539-x. [DOI] [PubMed] [Google Scholar]
  8. Curci G., Ninni A., Iodice F. Quelques considérations sur la pharmacocinétique de la rifampicine. Acta Tuberc Pneumol Belg. 1969;60(3):276–287. [PubMed] [Google Scholar]
  9. Daschner F., Marget W. Untersuchungen zur Anwendung des 7-Chlor-7-desoxylincomycin in der Kinderheilkunde. Arzneimittelforschung. 1969 Jun;19(6):1003–1006. [PubMed] [Google Scholar]
  10. Deal W. B., Sanders E. Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med. 1969 Sep 18;281(12):641–645. doi: 10.1056/NEJM196909182811203. [DOI] [PubMed] [Google Scholar]
  11. Furesz S. Recent investigations on the biological properties of rifampicin. Acta Tuberc Pneumol Belg. 1969;60(3):266–269. [PubMed] [Google Scholar]
  12. Furesz S., Scotti R., Pallanza R., Mapelli E. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man. Arzneimittelforschung. 1967 May;17(5):534–537. [PubMed] [Google Scholar]
  13. Garrison D. W., DeHaan R. M., Lawson J. B. Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin. Antimicrob Agents Chemother (Bethesda) 1967;7:397–400. [PubMed] [Google Scholar]
  14. Geddes A. M., Bridgwater F. A., Williams D. N., Oon J., Grimshaw G. J. Clinical and bacteriological studies with clindamycin. Br Med J. 1970 Jun 20;2(5711):703–704. doi: 10.1136/bmj.2.5711.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hartmann G., Honikel K. O., Knüsel F., Nüesch J. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta. 1967;145(3):843–844. doi: 10.1016/0005-2787(67)90147-5. [DOI] [PubMed] [Google Scholar]
  16. Harwick H. J., Fekety F. R., Jr The antibiotic susceptibility of Mycoplasma hominis. J Clin Pathol. 1969 Jul;22(4):483–485. doi: 10.1136/jcp.22.4.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ingham H. R., Selkon J. B., Codd A. A., Hale J. H. The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro. J Clin Pathol. 1970 Apr;23(3):254–258. doi: 10.1136/jcp.23.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jensen K. Methicillin-resistant staphylococci. Lancet. 1968 Nov 16;2(7577):1078–1078. doi: 10.1016/s0140-6736(68)91549-3. [DOI] [PubMed] [Google Scholar]
  19. Kanee B. Clindamycin in the treatment of pyoderma. Appl Ther. 1969 Sep;11(9):482–passim. [PubMed] [Google Scholar]
  20. Kohn J., Evans A. J. Group A streptococci resistant to clindamycin. Br Med J. 1970 May 16;2(5706):423–423. doi: 10.1136/bmj.2.5706.423-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kohn J., Hewitt J. H., Fraser C. A. Group A streptococci resistant to lincomycin. Br Med J. 1968 Mar 16;1(5593):703–703. doi: 10.1136/bmj.1.5593.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kunin C. M., Brandt D., Wood H. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. J Infect Dis. 1969 Feb;119(2):132–137. doi: 10.1093/infdis/119.2.132. [DOI] [PubMed] [Google Scholar]
  23. LOWBURY E. J., HURST L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. J Clin Pathol. 1959 Mar;12(2):163–169. doi: 10.1136/jcp.12.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Magerlein B. J., Birkenmeyer R. D., Kagan F. Chemical modification of lincomycin. Antimicrob Agents Chemother (Bethesda) 1966;6:727–736. [PubMed] [Google Scholar]
  25. McCabe W. R., Lorian V. Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci. 1968 Oct;256(4):255–265. doi: 10.1097/00000441-196810000-00007. [DOI] [PubMed] [Google Scholar]
  26. McGehee RF R., Barre F. F., Finland M. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. Antimicrob Agents Chemother (Bethesda) 1968;8:392–397. [PubMed] [Google Scholar]
  27. McGehee R. F., Jr, Smith C. B., Wilcox C., Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci. 1968 Nov;256(5):279–292. doi: 10.1097/00000441-196811000-00002. [DOI] [PubMed] [Google Scholar]
  28. Meyers B. R., Kaplan K., Weinstein L. Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol. 1969 May;17(5):653–657. doi: 10.1128/am.17.5.653-657.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mitchell A. A. Chemotherapy of bronchitis. Br Med J. 1970 May 23;1(5707):481–482. doi: 10.1136/bmj.2.5707.481-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Murdoch J. M., Speirs C. F., Wright N., Wallace E. T. Rifampicin. Lancet. 1969 May 31;1(7605):1094–1094. doi: 10.1016/s0140-6736(69)91725-5. [DOI] [PubMed] [Google Scholar]
  31. Oppenheimer S., Turek M. Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin. Am J Med Sci. 1968 Nov;256(5):314–321. doi: 10.1097/00000441-196811000-00006. [DOI] [PubMed] [Google Scholar]
  32. Pelzl H. Klinische Erfahrungen bei der Behandlung chirurgischer Infektionen mit einem neuen Lincomycin-Derivat. Arzneimittelforschung. 1969 Jan;19(1):117–119. [PubMed] [Google Scholar]
  33. Phillips L., Fernandes R., Warren C. In-vitro comparison of erythromycin, lincomycin, and clindamycin. Br Med J. 1970 Apr 11;2(5701):89–90. doi: 10.1136/bmj.2.5701.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schlegel D., Hieber E. Praktische Erfahrungen mit 7-Chlor-7-desoxy-Lincomycin in der Kieferchirurgie. Zahnarztl Prax. 1969 Feb 15;20(4):37–40. [PubMed] [Google Scholar]
  35. Sensi P. Structure-activity relationships of rifamycin derivatives. Acta Tuberc Pneumol Belg. 1969;60(3):258–265. [PubMed] [Google Scholar]
  36. Verbist L. Rifampicin blood levels in man. Acta Tuberc Pneumol Belg. 1969;60(3):288–298. [PubMed] [Google Scholar]
  37. Wagner J. G., Novak E., Patel N. C., Chidester C. G., Lummis W. L. Absorption, excretion and half-life of clinimycin in normal adult males. Am J Med Sci. 1968 Jul;256(1):25–37. doi: 10.1097/00000441-196807000-00004. [DOI] [PubMed] [Google Scholar]
  38. Weisblum B., Davies J. Antibiotic inhibitors of the bacterial ribosome. Bacteriol Rev. 1968 Dec;32(4 Pt 2):493–528. [PMC free article] [PubMed] [Google Scholar]
  39. Willcox R. R., Morrison G. D., Cobbold R. J. Rifampicin (Rimactane) in the treatment of gonorrhoea. Br J Vener Dis. 1970 Apr;46(2):145–148. doi: 10.1136/sti.46.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zinnemann K., Frazer J. Chemotherapy of bronchitis. Br Med J. 1970 May 23;1(5707):481–481. doi: 10.1136/bmj.2.5707.481-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES